Recent PLSE News
- Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering • Business Wire • 06/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:16:33 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/04/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:04:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:14 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:18:24 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/28/2024 09:19:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 06:07:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 06:03:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:10:06 PM
- Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000 • Business Wire • 05/20/2024 08:05:00 PM
- Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting • Business Wire • 05/16/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:05:00 PM
- Pulse Biosciences Enhances Executive Leadership Team • Business Wire • 05/14/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 01:09:05 PM
- Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System • Business Wire • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:18:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:14:47 PM
- Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results • Business Wire • 05/07/2024 08:05:00 PM
- Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000 • Business Wire • 05/02/2024 12:00:00 PM
- Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024 • Business Wire • 04/24/2024 08:05:00 PM
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results • Business Wire • 03/28/2024 08:12:00 PM
- Pulse Biosciences Announces Plans to Initiate a Rights Offering • Business Wire • 03/28/2024 08:10:00 PM
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024 • Business Wire • 03/14/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 01:10:42 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM